ATLAS / Macro Radar / Reporting / ESLA

Estrella Immunopharma, Inc. (ESLA) reporting calendar

Estrella Immunopharma, Inc. files periodic reports with the SEC as ESLA on Nasdaq. Atlas tracks 18 filed reports for this issuer, each linked to its original EDGAR accession.

Next window
22 Jul 2026 – 6 Sep 2026
Latest report
10-Q
Period ended
31 Mar 2026
Filed
18 May 2026
Reports on record
18

How this window is derived. Derived from this issuer's own filing history: 9 periods at a median 91-day cadence, filed a median 45 days after period end. The SEC does not publish forward reporting dates and Atlas does not estimate one.

Open ESLA market profile Latest filing on SEC EDGAR ↗ Biological Products, (No Diagnostic Substances) reporting datesAll Nasdaq reporting dates

Filed periodic reports

FormPeriod endedFiledLagSEC accession
10-Q31 Mar 202618 May 202648 days0001213900-26-058063
10-K31 Dec 202518 Mar 202677 days0001213900-26-029357
10-Q30 Sep 202512 Nov 202543 days0001213900-25-109198
10-Q30 Jun 202512 Aug 202543 days0001213900-25-074567
10-Q31 Mar 202514 May 202544 days0001213900-25-043365
10-Q30 Sep 202414 Nov 202445 days0001213900-24-098450
10-K30 Jun 202427 Sep 202489 days0001213900-24-082374
10-Q31 Mar 202415 May 202445 days0001213900-24-043126
10-Q31 Dec 202314 Feb 202445 days0001213900-24-014191
10-Q30 Sep 202320 Nov 202351 days0001213900-23-088827
10-Q30 Jun 20231 Aug 202332 days0001213900-23-061563
10-Q31 Mar 202318 May 202348 days0001575872-23-000781
10-K31 Dec 202214 Mar 202373 days0001575872-23-000353
10-Q30 Sep 202214 Nov 202245 days0001575872-22-001112
10-Q30 Jun 20228 Aug 202239 days0001410578-22-002124
10-Q31 Mar 202216 May 202246 days0001410578-22-001647
10-K31 Dec 202129 Mar 202288 days0001410578-22-000598
10-Q30 Sep 202110 Nov 202141 days0001410578-21-000091

Source: SEC EDGAR company submissions for CIK 0001844417. Atlas publishes filed facts only. The SEC does not publish forward reporting dates, so no announced future date is claimed here.